CANDRIAM S.C.A. – Arrowhead Pharmaceuticals, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$14.80M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
-6.13%
quarter
Arrowhead Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +18.11% | 68.68K shares | 1.45M | $33.05 | 448.05K |
| Q2 2022 | share | Increase | +40.48% | 109.31K shares | 938K | $35.21 | 379.36K |
| Q1 2022 | share | Increase | +356.27% | 210.86K shares | 8.49M | $45.99 | 270.05K |
| Q4 2021 | share | Decrease | -69.87% | -137.22K shares | -8.33M | $67.35 | 59.18K |
| Q3 2021 | share | 0.00% | 0 shares | -4.00M | $62.43 | 196.40K | |
| Q2 2021 | share | Increase | +19.79% | 32.45K shares | 4.18M | $82.82 | 196.40K |
| Q1 2021 | share | 0.00% | 0 shares | -497K | $66.31 | 163.95K | |
| Q4 2020 | share | Decrease | -39.53% | -107.18K shares | 906K | $76.73 | 163.95K |
| Q3 2020 | share | Decrease | -15.57% | -50K shares | -2.19M | $43.06 | 271.14K |
| Q2 2020 | share | Increase | +13.68% | 38.63K shares | -3.64M | $43.19 | 321.14K |
| Q1 2020 | share | 0.00% | 0 shares | -402K | $28.77 | 282.50K | |
| Q4 2019 | share | Decrease | -63.97% | -501.49K shares | -4.17M | $63.43 | 282.50K |
| Q3 2019 | share | Increase | +48.20% | 255K shares | 8.13M | $28.18 | 784K |
| Q2 2019 | share | Decrease | -10.94% | -65K shares | 3.05M | $26.5 | 529K |
| Q1 2019 | share | 0.00% | 0 shares | 3.52M | $18.35 | 594K | |
| Q4 2018 | share | Increase | +15.56% | 80K shares | -2.47M | $12.42 | 594K |
| Q3 2018 | share | Increase | 0.00% | 514K shares | 9.85M | $19.17 | 514K |